Log In
Print
BCIQ
Print
Print this Print this
 

Oxaydo, oxycodone (Aversion) (formerly Acurox, Oxecta)

  Manage Alerts
Collapse Summary General Information
Company Acura Pharmaceuticals Inc.
DescriptionOral immediate-release oxycodone tablets without niacin utilizing Aversion abuse-deterrent technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat acute and chronic moderate to severe pain; Treat moderate to severe pain
Regulatory Designation U.S. - Priority Review (Treat moderate to severe pain)
Partner Egalet Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$20.0M

$5.0M

$15.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today